Skip to main content
Erschienen in: Clinical Rheumatology 6/2006

01.11.2006 | Review

The burden of musculoskeletal disease—a global perspective

verfasst von: Peter M. Brooks

Erschienen in: Clinical Rheumatology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Musculoskeletal diseases are one of the major causes of disability around the world and have been a significant reason for the development of the Bone and Joint Decade. Rheumatoid arthritis, osteoarthritis and back pain are important causes of disability-adjusted-life years in both the developed and developing world. COPCORD studies in over 17 countries around the world have identified back and knee pain as common in the community and are likely to increase with the ageing population. Musculoskeletal conditions are an enormous cost to the community in economic terms, and these figures emphasise how governments need to invest in the future and look at ways of reducing the burden of musculoskeletal diseases by encouraging exercise and obesity prevention campaigns.
Literatur
1.
Zurück zum Zitat Brooks PM (2004) Musculoskeletal medicine: the challenge of the Bone and Joint Decade. APLAR J Rheumatol 7:272–277CrossRef Brooks PM (2004) Musculoskeletal medicine: the challenge of the Bone and Joint Decade. APLAR J Rheumatol 7:272–277CrossRef
2.
Zurück zum Zitat World Health Organisation (2003) The burden of musculoskeletal conditions at the start of the new millennium. (WHO Technical Report Series 919). World Health Organisation, Geneva World Health Organisation (2003) The burden of musculoskeletal conditions at the start of the new millennium. (WHO Technical Report Series 919). World Health Organisation, Geneva
3.
Zurück zum Zitat Hazes JA, Woolf AD (2000) The Bone and Joint Decade 2000–2010. J Rheumatol 27:1–3PubMed Hazes JA, Woolf AD (2000) The Bone and Joint Decade 2000–2010. J Rheumatol 27:1–3PubMed
4.
Zurück zum Zitat Mathers CD, Vos ET, Stevenson CE, Begg SJ (2000) The Australian burden of disease study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 172:592–596PubMed Mathers CD, Vos ET, Stevenson CE, Begg SJ (2000) The Australian burden of disease study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 172:592–596PubMed
5.
Zurück zum Zitat Darmawan J, Valkenburg HA, Muirden KD, Wigley RD (1992) Epidemiology of the rheumatic diseases in rural and urban populations in Indonesia; a World Health organisation international league against rheumatism COPCORD study, stage 1, phase 2. Ann Rheum Dis 51:525–528PubMedCrossRef Darmawan J, Valkenburg HA, Muirden KD, Wigley RD (1992) Epidemiology of the rheumatic diseases in rural and urban populations in Indonesia; a World Health organisation international league against rheumatism COPCORD study, stage 1, phase 2. Ann Rheum Dis 51:525–528PubMedCrossRef
6.
Zurück zum Zitat Manahan L, Caragay R, Muirden K.D Allander E, Valkenberg HA Wigley RD (1985) Rheumatic pain in a Philippine village. A WHO/COPCORD study. Rheumatol Int 5:149–153CrossRefPubMed Manahan L, Caragay R, Muirden K.D Allander E, Valkenberg HA Wigley RD (1985) Rheumatic pain in a Philippine village. A WHO/COPCORD study. Rheumatol Int 5:149–153CrossRefPubMed
7.
Zurück zum Zitat Muirden KD (1997) The origins, evolution and future of COPCORD. APLAR J Rheumatol 1:44–48 Muirden KD (1997) The origins, evolution and future of COPCORD. APLAR J Rheumatol 1:44–48
8.
Zurück zum Zitat Zeng QY, Chen R, Xiao ZY et al (2004) Low prevalence of knee and back pain in Southeast China; the Shantou COPCORD study. J Rheumatol 31:2439–2443PubMed Zeng QY, Chen R, Xiao ZY et al (2004) Low prevalence of knee and back pain in Southeast China; the Shantou COPCORD study. J Rheumatol 31:2439–2443PubMed
9.
Zurück zum Zitat Chopra A, Saluja M, Patil J, Tandale H (2002) Pain and disability, perceptions and beliefs of a rural Indian population: A WHO-ILAR COPCORD study. J Rheumatol 29:614–621PubMed Chopra A, Saluja M, Patil J, Tandale H (2002) Pain and disability, perceptions and beliefs of a rural Indian population: A WHO-ILAR COPCORD study. J Rheumatol 29:614–621PubMed
10.
Zurück zum Zitat Chopra A (2004) COPCORD—an unrecognised fountainhead of community rheumatology in developing countries. J Rheumatol 31:2320–2321PubMed Chopra A (2004) COPCORD—an unrecognised fountainhead of community rheumatology in developing countries. J Rheumatol 31:2320–2321PubMed
12.
Zurück zum Zitat Blyth FM, March LM, Cousins MJ (2003) Chronic pain-related disability and use of analgesia and health services in a Sydney community. Med J Aust 179:84–87PubMed Blyth FM, March LM, Cousins MJ (2003) Chronic pain-related disability and use of analgesia and health services in a Sydney community. Med J Aust 179:84–87PubMed
13.
Zurück zum Zitat Harkness EF, Macfarlane GJ, Silman AJ, McBeth J (2005) Is musculoskeletal pain more common now than forty years ago?: two population- based cross-sectional studies. Rheumatology 44:890–895CrossRefPubMed Harkness EF, Macfarlane GJ, Silman AJ, McBeth J (2005) Is musculoskeletal pain more common now than forty years ago?: two population- based cross-sectional studies. Rheumatology 44:890–895CrossRefPubMed
14.
15.
Zurück zum Zitat Deltonen M, Lindross AK, Torgerson JS (2003) Musculoskeletal pain in the obese: a comparison with a general population and long term changes after conventional and surgical obesity treatment. Pain 104:549–557CrossRefPubMed Deltonen M, Lindross AK, Torgerson JS (2003) Musculoskeletal pain in the obese: a comparison with a general population and long term changes after conventional and surgical obesity treatment. Pain 104:549–557CrossRefPubMed
16.
Zurück zum Zitat O’Neil TW (2005) Looking back: developments in our understanding of the occurence, aetiology and prognosis of osteoporosis over the last 50 years. Rheumatology 44:(Supplement 4)33–35 O’Neil TW (2005) Looking back: developments in our understanding of the occurence, aetiology and prognosis of osteoporosis over the last 50 years. Rheumatology 44:(Supplement 4)33–35
17.
Zurück zum Zitat Melton LJ (1995) Epidemiology of fractures: In Rigg BL and Melton LJ (Eds) Osteoporosis: Aetiology, diagnosis and management. Philadelphia, Lippincott Raven:225–247 Melton LJ (1995) Epidemiology of fractures: In Rigg BL and Melton LJ (Eds) Osteoporosis: Aetiology, diagnosis and management. Philadelphia, Lippincott Raven:225–247
18.
Zurück zum Zitat Segal L, Day SE, Chapman AB, Osbourne RH (2003) Can we reduce disease burden from osteoarthritis—an evidence based priority setting model. Med J Aust 180:S11–S17 Segal L, Day SE, Chapman AB, Osbourne RH (2003) Can we reduce disease burden from osteoarthritis—an evidence based priority setting model. Med J Aust 180:S11–S17
19.
Zurück zum Zitat March LM, Lapsley HM, Cross MJ, Byrne E, Courtenay BG, Brooks PM (2005) Expenditure, outcomes and satisfaction 8 years after hip and knee replacement. Abstr. Australian Rheumatology Association annual scientific meeting, Melbourne March LM, Lapsley HM, Cross MJ, Byrne E, Courtenay BG, Brooks PM (2005) Expenditure, outcomes and satisfaction 8 years after hip and knee replacement. Abstr. Australian Rheumatology Association annual scientific meeting, Melbourne
Metadaten
Titel
The burden of musculoskeletal disease—a global perspective
verfasst von
Peter M. Brooks
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 6/2006
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0240-3

Weitere Artikel der Ausgabe 6/2006

Clinical Rheumatology 6/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.